Camylofin
![]() | |
| Gene therapy | |
|---|---|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C19H32N2O2 |
| Molar mass | 320.47 g/mol |
| 3D model (JSmol) | |
| |
| |
| Template:Xmark | |
|
WikiDoc Resources for Camylofin |
|
Articles |
|---|
|
Most recent articles on Camylofin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Camylofin at Clinical Trials.gov Clinical Trials on Camylofin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Camylofin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Camylofin Discussion groups on Camylofin Directions to Hospitals Treating Camylofin Risk calculators and risk factors for Camylofin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Camylofin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Camylofin is an antimuscarinic.
It is used to treat stomach ache in infants and children. Usually it is given in combination with paracetamol to treat stomach ache, as well as pyrexia.
References
- Articles with short description
- Template:drugs.com link with non-standard subpage
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- Infobox-drug molecular-weight unexpected-character
- Articles with changed InChI identifier
- Pages using infobox drug with unknown parameters
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Amines
- Carboxylate esters
- Drug
